Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 133

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 5
Chunk 133
---
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Shares of our common stock trade on the New York Stock Exchange under the ticker symbol “EHC.”

Holders

As of February 13, 2025, there were 100,709,106 shares of Encompass Health common stock issued and outstanding, net of treasury shares, held by approximately 6,266 holders of record (participant positions at The Depository Trust Corporation plus record holders).

Dividends

On October 17, 2024, our board of directors declared a cash dividend of $0.17 per share, payable on January 15, 2025 to stockholders of record on January 2, 2025. We expect quarterly dividends to continue to be paid in January, April, July, and October. However, the actual declaration of any future cash dividends, and the setting of record and payment dates as well as the per share amounts, will be at the discretion of our board each quarter after consideration of various factors, including our capital position and alternative uses of funds.

Recent Sales of Unregistered Securities

None.

Securities Authorized for Issuance Under Equity Compensation Plans 

The following table sets forth, as of December 31, 2024, information concerning compensation plans under which our securities are authorized for issuance. The table does not reflect grants, awards, exercises, terminations, or expirations since that date. Pursuant to the terms of the equity plans, all share amounts and exercise prices have been adjusted to reflect the spin off of our home health and hospice business on July 1, 2022 and stock splits that occurred after the date on which any particular underlying plan was adopted, to the extent applicable.

Number of securities to be issued upon exercise of outstanding optionsWeighted-average exercise price of outstanding options(1)Number of securities available for future issuancePlans approved by stockholders3,282,172 (2)$53.05 5,537,035 (3)Plans not approved by stockholders77,090 (4)— Total3,359,262 $53.05 5,537,035 

(1)    This calculation does not take into account awards of restricted stock, restricted stock units, or performance share units.

(2)    This amount assumes maximum performance by performance-based awards for which the performance has not yet been determined.

(3)    This